![Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection](https://www.frontiersin.org/files/Articles/997013/fcvm-09-997013-HTML/image_m/fcvm-09-997013-g002.jpg)
Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection
![Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection](https://www.frontiersin.org/files/MyHome%20Article%20Library/997013/997013_Thumb_400.jpg)
Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection
Avanza on Twitter: "@indexjagaren Innehaven i fonden presenteras efter månadsskiftet, men om du är nyfiken kan du redan nu se de största innehaven i fonden i det här blogginlägget 😄 https://t.co/6ZRyEmYskc" /
![Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection](https://www.frontiersin.org/files/Articles/997013/fcvm-09-997013-HTML/image_m/fcvm-09-997013-g005.jpg)
Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection
![Advanced Nanoscale Build‐Up Sensors for Daily Life Monitoring of Diabetics - El‐Safty - 2020 - Advanced Materials Interfaces - Wiley Online Library Advanced Nanoscale Build‐Up Sensors for Daily Life Monitoring of Diabetics - El‐Safty - 2020 - Advanced Materials Interfaces - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e52e022f-a21d-4da8-ae6b-e27517692c4a/admi202000153-gra-0001-m.jpg?trick=1684742441925)
Advanced Nanoscale Build‐Up Sensors for Daily Life Monitoring of Diabetics - El‐Safty - 2020 - Advanced Materials Interfaces - Wiley Online Library
![David NATHANSON | Professor (Associate) | MD, PhD | Karolinska Institutet, Solna | KI | Department of Medicine, Huddinge | Research profile David NATHANSON | Professor (Associate) | MD, PhD | Karolinska Institutet, Solna | KI | Department of Medicine, Huddinge | Research profile](https://i1.rgstatic.net/ii/profile.image/587473717563392-1517076057055_Q512/David-Nathanson-2.jpg)
David NATHANSON | Professor (Associate) | MD, PhD | Karolinska Institutet, Solna | KI | Department of Medicine, Huddinge | Research profile
LinkedIn Bengt Eliasson 페이지: What a good summary and snapshot of some side-events during NRF Big Show…
![The inTandem 2 study: 52-week efficacy and safety of sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in adults with type 1 diabetes - Media Centre | EASD The inTandem 2 study: 52-week efficacy and safety of sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in adults with type 1 diabetes - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/885_726488/Slide1.jpg)
The inTandem 2 study: 52-week efficacy and safety of sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in adults with type 1 diabetes - Media Centre | EASD
![2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005](https://onlinelibrary.wiley.com/cms/asset/f2a6398c-7c76-4874-aeb7-901c0cd6f4f7/ccd.v101.6.cover.jpg)
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005
![Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection](https://www.frontiersin.org/files/Articles/997013/fcvm-09-997013-HTML/image_m/fcvm-09-997013-g003.jpg)
Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection
![Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection](https://www.frontiersin.org/files/Articles/997013/fcvm-09-997013-HTML/image_m/fcvm-09-997013-g001.jpg)